Company profile
Novartis Venture Fund
Investors & Funds · Basel, Switzerland
About the company
Novartis Venture Fund is a corporate venture capital arm of Novartis, investing in innovative life science companies across North America, Europe, and Israel. The fund focuses on pioneering biotechnology and biopharmaceutical companies developing novel therapeutics and platforms to address unmet patient needs, with over USD 750 million in committed capital. They support ventures from seed to later stages, aiming to drive significant patient benefit and generate superior returns.
Official links
Explore the full company profile
Explore company Access the complete profile and structured research in the Explorer with eligible account access.